SG Americas Securities’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,143
Closed -$64K 3165
2024
Q3
$64K Buy
6,143
+3,709
+152% +$61.7K ﹤0.01% 3191
2024
Q2
$48K Sell
2,434
-1,568
-39% -$31.4K ﹤0.01% 2677
2024
Q1
$102K Buy
4,002
+3,286
+459% +$84.2K ﹤0.01% 2551
2023
Q4
$20K Buy
+716
New +$43.7K ﹤0.01% 3004
2023
Q2
Sell
-2,103
Closed -$134K 2353
2023
Q1
$134K Buy
2,103
+914
+77% +$104K ﹤0.01% 2717
2022
Q4
$164K Buy
1,189
+307
+35% +$43.3K ﹤0.01% 2349
2022
Q3
$112K Sell
882
-531
-38% -$60.1K ﹤0.01% 2780
2022
Q2
$117K Buy
1,413
+807
+133% +$62.6K ﹤0.01% 3020
2022
Q1
$59K Sell
606
-534
-47% -$70.5K ﹤0.01% 2826
2021
Q4
$228K Sell
1,140
-2,097
-65% -$495K ﹤0.01% 2603
2021
Q3
$801K Buy
3,237
+422
+15% +$121K ﹤0.01% 2094
2021
Q2
$1.17M Buy
2,815
+1,137
+68% +$450K 0.01% 1462
2021
Q1
$655K Buy
+1,678
New +$826K ﹤0.01% 1823
2020
Q4
Sell
-2,289
Closed -$1.45M 3337
2020
Q3
$1.6M Buy
2,289
+1,759
+332% +$1.37M 0.01% 888
2020
Q2
$419K Sell
530
-1,503
-74% -$1.13M ﹤0.01% 2244
2020
Q1
$1.21M Buy
2,033
+1,913
+1,594% +$1.86M 0.01% 1157
2019
Q4
$136K Buy
120
+16
+15% +$17.4K ﹤0.01% 2759
2019
Q3
$124K Sell
104
-148
-59% -$226K ﹤0.01% 2619
2019
Q2
$415K Buy
252
+149
+145% +$258K ﹤0.01% 1998
2019
Q1
$209K Sell
103
-11
-10% -$19.4K ﹤0.01% 2531
2018
Q4
$146K Buy
114
+1
+0.9% +$1.53K ﹤0.01% 2529
2018
Q3
$214K Buy
+113
New +$233K ﹤0.01% 2529
2018
Q2
Sell
-263
Closed -$582K 3328
2018
Q1
$582K Buy
+263
New +$669K ﹤0.01% 1768
2017
Q4
Sell
-307
Closed -$547K 3207
2017
Q3
$547K Buy
307
+157
+105% +$219K ﹤0.01% 1771
2017
Q2
$204K Buy
150
+23
+18% +$27.8K ﹤0.01% 2412
2017
Q1
$150K Sell
127
-963
-88% -$982K ﹤0.01% 2658
2016
Q4
$871K Sell
1,090
-178
-14% -$141K 0.01% 1378
2016
Q3
$1.11M Buy
+1,268
New +$918K 0.01% 1091
2015
Q4
Sell
-706
Closed -$782K 2706
2015
Q3
$782K Buy
706
+649
+1,139% +$1.18M ﹤0.01% 940
2015
Q2
$123K Sell
57
-449
-89% -$915K ﹤0.01% 2238
2015
Q1
$792K Buy
506
+51
+11% +$67.3K ﹤0.01% 1244
2014
Q4
$541K Buy
+455
New +$304K ﹤0.01% 1601

Other funds holding BLUE

SG Americas Securities's BLUE Position: Q4 2024 in Review

SG Americas Securities sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 6,143 shares — an estimated $64K sold.

SG Americas Securities first reported a position in BLUE in Q4 2014 and held it in 32 quarters. The position peaked at $1.6M in Q3 2020. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • SG Americas Securities reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • SG Americas Securities sold 6,143 bluebird bio shares in Q4 2024, an estimated $64K.
  • SG Americas Securities first reported a position in bluebird bio in Q4 2014 and held it in 32 quarters.
  • SG Americas Securities's bluebird bio position peaked at $1.6M in Q3 2020.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on SG Americas Securities's 13F filing for Q4 2024, filed 17 Jan 2025.